Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why would they not accept a buyout for everyone's interest? It's been obvious Leo's not building this company outward... My guess they have a sale pending on results... Not expecting a large deal possibly a buck, buck and half...
Boo, Doesn't everything ride off data? Let it play out, if they miss the entire performance package will be worthless anyway... Rather see compensation tied to performance... As far as authorized shares it won't matter if they fold or are sold...
That's the mystery, what targets achieved trigger X,Y and Z... Examples... Buyout, PPS above 1 dollar, license deal ( X amount) and so on....
The reasoning for the 8k was to reward management and the BOD's if the stock goes higher due to partnership, sale or good data... Again, it's a moot point if data fails and who cares if insiders own a large portion of the company if successful... The key being what's next...
They may know results if Leo decided not to PR the lock.
Shouldn’t one look at today’s filing as based on performance? If they miss data it doesn’t matter. Actually I view this as positive. A sale or known good data.
Agree, if data is bad they are finished regardless of today’s filing. Maybe there’s positive news on the way.
Expecting news soon, not concerned about the filing either way it comes down to results.
Does appear this is heading into November unless we see a lock PR this week... Leo carefully worded the last PR as anticipated mid to late October... It's already mid and soon to be late.... Also, he stated data a week after a lock... So did they lock yet?
There's no urgency to do anything and why they sat on hiring positions? If there's no need to hire employees past 2 or 3 why should anyone invest here? The main reason many are posting is the hope of recovering huge losses.... Some missed getting out over .50... Now everything rides on data...
The trend is higher at .22? LOL Not much confidence for upcoming data results. Leo's 6 months and counting to make much difference... If they don't get EUA it will be shelved like Absssi/OM and K...
Or in the case of Prurisol drag this out sitting on negative data..... A data lock PR occurred in July, data wasn’t released for 5 months. Why this fraud CEO has an approval rating of 22 cents per share.
Agree, If B was a miracle drug word would have leaked out from Russia... Always get a kick out of blind trial... So nobody in Russia who administered B or subjects in the trial knew it was B? LOL
100 million IPIX valuation is more than fair enough for 2 employees and no plan to share with shareholders. Those who continue to blame others for the lame PPS are in fantasy world... Why a drop back to 6 pennies or less would be expected with a data miss.... B for C would then be wiped off IPIX's site like Prurisol... All that would be left is when IPIX will fold and would someone pay for the scraps... Polymedix round 2....
In other IPIX news this year... LOL Did Leo accomplish anything outside trial completion which was setup ahead of 2021? So obvious they have zero going on except to keep paying Leo/Jane half a million.
No buying interest today as two sellers keep lowering the ask trying to compete for dump position. We all knew time was critical to get results it's taking too long... There won't be a need for B in late 2023 at this rate... Phase 3 who pays?
When has Leo delivered anything on schedule? They anticipate data mid to late October? He also mentioned data would be announced a week after the lock. The fun continues in penny world. The 2 person operation is preparing for big things!!!
Better strategy would be to sell out ahead of data and protect what’s left with an option to buy back in. If results miss your sitting gold never returning to this loser. The lock PR may spur some interest to the .30 range a good time to unload. Also, even if results are good what’s the plan? A one or two day pop with the usual sell off would be expected.
Reverse trend from .25 back to .20. Rallies with no volume was a setup... Judgement day in 4 weeks. Finally IPIX will fold or sold for 50 pennies.
Down 7 percent now what an investment... 100 million market cap that can swing 10 to 15 percent on a 10K trade.
The big question is what stage would B be recommended and would there be any logic to run an expensive phase 3 for limited return? Further testing is an option but they need an immediate impact not 5 years of more the same. Leo/Jane and pray for rain.
Who bought above .25? They really haven’t learned a lesson in buying IPIX. Never over reach when you can get a much lower value in short time. This stock is purely news driven with the script by Leo so obvious. Lock PR in a few weeks one last chance to get out with some value.
The area is home to Leo and his board of directors. It’s been known since the FB poster revealed the use of B for a family member. Start with the hospitals in and around Boca Raton.
Little volume is a concern since one large sell order would wipe most of the gains from .20. Same old story here in penny land.
Until Leo issues a lock PR tack on another week or two for results. I’m not expecting data until mid November.
Side effects after one day throws a red flag for validation. Even the Facebook poster who claimed COVID free would have to be analyzed to confirm. The trial will be more accurate than those in severe conditions with mentions on Twitter/FB.
Old news, one patient passed away, one was COVID free still hanging in there.
Merck’s pill side effects issue..... https://www.foxnews.com/health/merck-pill-oral-covid-treatment
Sweden halts Moderna vaccines for younger population. https://www.reuters.com/business/healthcare-pharmaceuticals/sweden-pauses-use-moderna-covid-vaccine-cites-rare-side-effects-2021-10-06/
Leo said mid to late October. Once we see a data lock PR tack on another week or two. My guess mid November....
From April 2020 until a few months ago all Leo did was hype B to death. Now he changes tune or tempers excitement with reality about to unfold? Believe it’s more about protecting himself from lawsuits than the FDA.
Agree and exactly why the last BDD trial was specific for the colon... So knowing a pill therapeutic has more value than injection surprised we have not heard from Leo on this? He was always one to mention possibilities going forward and it's like he's given up...
Our response to the Merck news is that we believe B will be more effective and plan to pursue a pill delivery option once we confirm the data....
WTH does he have to lose at this point...
Volume dropping off recently big-time....
Yes, why it would have been nice to see a trial using a B capsule/pill... Shouldn't be that difficult to alter how B is being deployed... Obviously, they have more previous data to support an injection which the FDA gave a blessing for a P2.
Wouldn't it make sense for Moderna to buy IPIX out and speed rush a pill form if data shows more potential than Merck? Pfizer has a pill in the works but don't believe Moderna has....
CV19 Vaccines losing effectiveness over time. If B's data shows a much better option than Merck should rally the PPS above a buck... How fast can IPIX get a pill formation onboard/tested is another story...
https://www.foxbusiness.com/economy/some-vaccines-last-a-lifetime-heres-why-covid-19-shots-dont
Any reason why Leo couldn't have used OralogiK's pill technology for the P2 trial? If they have to go this route for a P3 they wasted a year... They would be sitting pretty knowing Merck's 50 percent COVID reduction was the hyped result. The technology was targeted the Colon area but demonstrated B was effective.
www.ipharminc.com/press-release/2020/2/13/innovation-pharmaceuticals-phase-1-trial-of-brilacidin-for-ulcerative-colitis-meets-primary-endpoints-positive-topline-results-of-oral-brilacidin
“BDD are delighted to have successfully completed the first oral dosing study of Brilacidin, which has demonstrated the capability of its OralogiK™ Technology to deliver
Given Brilacidin has shown clinical efficacy with limited absorption in other clinical trials, in Ulcerative Proctitis/Ulcerative Proctosigmoiditis and Oral Mucositis, these results suggest oral Brilacidin for IBD might be safely dosed at even higher levels of drug via targeted release tablet.
Leo's CEO days will be finished if there's a data miss... Only B for C gave IPIX life another 2 years... They were heading towards a PolyMedix fate in 2020 with the PPS hitting 6 pennies that January... If they have to resort back to promoting Alphasigma/Locust Walk the stock will go sub penny and finish them off... Maybe B will fetch 5 million from someone as K is worthless.
Why would there be a rush to buy shares when Leo still hasn't submitted a lock PR... Also, many will wait for data and won't bother if they miss....
Ready for the afternoon plunge back to unchanged... Judgement day 4 weeks away...